NCT03157934

Brief Summary

FAST is an investigator-initiated multicenter study embedded in a German multistate acute stroke network. The main objectives of the FAST study are to improve outcomes and quality of care for stroke patients, to quantify the number of patients in need of thrombectomy within an integrated stroke network, to study the best way of delivering and performing thrombectomy and to investigate the best model of pre-hospital selection and referral for stroke patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

October 26, 2017

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

6.1 years

First QC Date

May 16, 2017

Last Update Submit

November 28, 2023

Conditions

Keywords

stroke networkacute stroke careemergency medical servicesintegrated care

Outcome Measures

Primary Outcomes (1)

  • Functional outcome

    Functional outcome according to the modified Rankin Scale (mRS)

    3 months after intervention

Secondary Outcomes (2)

  • Number of patients receiving acute recanalisation therapies of all referrals

    24 h after stroke onset

  • Referral rates

    Stroke onset to discharge from acute hospital; through study completion, an average of 2 years

Study Arms (3)

Primary CSC (Comprehensive Stroke center) admission

Patients with primary admission to endovascular-ready hospital (comprehensive stroke center)

Other: not applicable (observational study)

Primary non-CSC (non-Comprehensive Stroke Center) SU (Stroke Unit) admission

Patients with primary admission to non-endovascular-ready hospital with (regional/local) stroke unit

Other: not applicable (observational study)

Non-acute stroke hospital admission

Patients with primary admission to non-acute stroke-ready hospital

Other: not applicable (observational study)

Interventions

Observational study without study related intervention

Non-acute stroke hospital admissionPrimary CSC (Comprehensive Stroke center) admissionPrimary non-CSC (non-Comprehensive Stroke Center) SU (Stroke Unit) admission

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Acute stroke patients admitted to one of the hospitals of the Stroke Consortium Rhein-Neckar (FAST)

You may qualify if:

  • years or older
  • Patients with ischemic stroke who are admitted to one of the hospitals of the Stroke Consortium Rhein-Neckar (FAST)
  • informed consent

You may not qualify if:

  • no informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heidelberg University Hospital

Heidelberg, 69120, Germany

RECRUITING

Related Links

MeSH Terms

Conditions

Ischemic StrokeVascular DiseasesCardiovascular Diseases

Interventions

Observation

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Wolfgang Wick, Prof. Dr.

    University Hospital Heidelberg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman of the Neurologic Clinic

Study Record Dates

First Submitted

May 16, 2017

First Posted

May 17, 2017

Study Start

October 26, 2017

Primary Completion

December 1, 2023

Study Completion

March 1, 2024

Last Updated

November 29, 2023

Record last verified: 2023-11

Locations